Target intelligence / Profile preview

Mago homolog 2, pseudogene (MAGOH2P)

Target: MAGOH2P
Molecular classification: Pseudogene

Overview

MAGOH2P (Mago homolog 2, pseudogene) is a segment of DNA homologous to the protein-coding mago homolog genes but contains mutations that abolish its ability to encode a functional protein[1][2][4]. Pseudogenes like MAGOH2P arise through gene duplication or retrotransposition and subsequent disabling mutations[3][4]. Although a minority of pseudogenes may have regulatory roles via RNA in specific cases, there is no evidence that MAGOH2P has such a function. Pseudogenes can pose technical challenges in genetic studies, such as complicating genetic assays through sequence similarity, but are not considered drug targets, receptors, or functional molecules for therapeutic modulation[2][4]. MAGOH2P is cataloged in genomic databases for reference and annotation purposes only[1].

Other names: MAGOH2Mago homolog 2, pseudogene

Mechanism of action

None (no drugs or therapies act on this pseudogene)

Biological functions

Not implicated in direct biological functions due to lack of protein-coding capability

Disease associations

None formally assigned; pseudogenes generally do not have direct disease roles, though some pseudogenes can indirectly regulate real genes via RNA mechanisms in other contexts, not demonstrated for MAGOH2P

Safety considerations

None; as MAGOH2P is not targeted pharmacologically and does not encode a protein

Interacting drugs

None (no drugs interact with MAGOH2P or target it therapeutically)

Biomarkers

None known for MAGOH2P

Beyond the preview

Go deeper on Mago homolog 2, pseudogene (MAGOH2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mago homolog 2, pseudogene (MAGOH2P).

Explore the full profile